CBT

CBT

USD

Cabot Corporation Common Stock

$77.990+0.110 (0.141%)

Echtzeitkurs

Grundstoffe
Spezialchemikalien
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$77.880

Hoch

$78.851

Tief

$76.940

Volumen

0.08M

Unternehmensfundamentaldaten

Marktkapitalisierung

4.2B

Branche

Spezialchemikalien

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.46M

Börse

NYQ

Währung

USD

52-Wochen-Spanne

Tief $73.63Aktuell $77.990Hoch $117.46

KI-Analysebericht

Zuletzt aktualisiert: 3. Mai 2025
KI-generiertDatenquelle: Yahoo Finance, Bloomberg, SEC

CBT: Cabot Corporation Stock - What's Happening and What to Watch

Stock Symbol: CBT Generate Date: 2025-05-03 14:27:32

Alright, let's break down what's been going on with Cabot Corporation (CBT) and what the tea leaves seem to be suggesting right now. We'll look at the latest news, how the stock price has been acting, and what some of the automated tools are predicting.

The Latest Buzz: News Sentiment Check

So, what's the general feeling from the recent headlines? It's a bit of a mixed bag, maybe leaning slightly cautious, but with a big event looming.

First off, there was news about ITT nominating someone to their board. Honestly, that doesn't really tell us anything specific about Cabot itself. It's just noise for CBT investors.

More importantly, a firm called UBS had their analyst, Joshua Spector, take another look at Cabot. What did they do? They kept their rating at "Neutral," which basically means they're not strongly recommending buying or selling right now. But, they did lower their price target for the stock, dropping it from $93 down to $83. Think of a price target as an analyst's guess at where the stock could trade in the future. Lowering it suggests they see less potential upside than before. That's a bit of a yellow flag.

Then there's the announcement that Cabot is getting ready to drop their second-quarter operating results on May 5th, right after the market closes. This isn't positive or negative news on its own, but it's super important. Earnings reports are when companies tell everyone how they've been doing financially. They often cause the stock price to jump or drop significantly depending on whether the results beat or miss expectations. This is the main thing to watch for in the very near future.

Putting the news together, we have an analyst getting a little less optimistic (lowering the price target) right before a major event (earnings) that could swing things either way.

Checking the Price Tag: What the Stock Chart Shows

Looking back at the last month or so of trading data, the price action for CBT has been pretty choppy. It started February up in the mid-$80s, even poking its head above $88 briefly. But then things got a bit rougher in March and April. We saw some notable dips, hitting lows in the mid-$70s in early April.

More recently, the stock has been bouncing around, mostly trading in the high $70s. It seems to be trying to find its footing after that April dip. The last few days show it hovering right around the $77-$78 mark.

Comparing this to the AI's prediction for today (May 3rd), which is essentially flat (0.00% change), that seems to line up with the stock's recent behavior – not making big moves right this second. However, the AI is predicting slight drops for the next couple of days (-1.81% and -2.07%). If that plays out, it would mean the stock drifts a bit lower from where it is now.

So, What's the Potential Outlook and What Could You Do?

Based on the news, the recent price action, and the AI's short-term forecast, the immediate picture for CBT looks cautious. The analyst downgrade and the AI predicting a slight dip suggest some potential near-term pressure.

However, there's a big asterisk here: the earnings report coming out on May 5th. That report is the real wild card. Good results could easily override the recent cautious sentiment and predictions, potentially sending the stock higher. Poor results could accelerate any downward trend.

Given this setup, the situation seems to lean towards a "Hold" or "Wait and See" for anyone considering a move right now, especially ahead of the earnings report. It's tough to make a confident directional bet until we see those numbers.

Now, if you were looking at potential price levels, the recommendation data points to possible entry areas around $77.85 and $78.26. These are right where the stock has been trading recently. The idea here might be that the stock is near a level where it could find support, if the overall picture improves or the earnings are good.

For managing risk, the recommendation suggests a stop-loss around $74.46. This level is below the recent lows we saw in April. Setting a stop-loss there is a way to limit potential losses if the stock price keeps falling significantly. On the flip side, a potential take-profit level is suggested around $79.56. This is slightly above recent trading and could be a point to consider selling some shares if the stock bounces up.

Remember, the recommendation data also tagged CBT as an "Undervalued Gem" for "Value" investors with a "Long-term" view, citing things like a low P/E ratio and high Return on Equity, despite some debt and negative recent revenue growth. This suggests that while the short-term picture is uncertain and potentially bumpy, some see longer-term fundamental value in the company.

A Little About Cabot

Just to quickly put this in context, Cabot Corporation is a specialty chemicals company. They make things like carbon black used in tires, fumed silica for coatings and batteries, and other materials. Their business performance is often tied to industrial production, the auto industry, and other manufacturing sectors. So, news and trends in those areas can definitely impact how Cabot does.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can move unexpectedly. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Ähnliche Nachrichten

BusinessWire

ITT Nominates Douglas DelGrosso for Election to Board of Directors

April 8, 2025-- ITT Inc. (NYSE: ITT) today announced the nomination of Douglas DelGrosso for election to its Board of Directors at the company's upcoming 2025 annual meeting of shareholders. Mr.

Mehr anzeigen
ITT Nominates Douglas DelGrosso for Election to Board of Directors
Analyst Upgrades

UBS Maintains Neutral on Cabot, Lowers Price Target to $83

UBS analyst Joshua Spector maintains Cabot with a Neutral and lowers the price target from $93 to $83.

Mehr anzeigen
UBS Maintains Neutral on Cabot, Lowers Price Target to $83
GlobeNewswire

Cabot Corporation to Announce Second Quarter 2025 Operating Results

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the second quarter of fiscal 2025 on Monday, May 5, 2025, after market close. The

Mehr anzeigen
Cabot Corporation to Announce Second Quarter 2025 Operating Results

KI-VorhersageBeta

KI-Empfehlung

Bärisch

Aktualisiert am: 4. Mai 2025, 08:13

BärischNeutralBullisch

58.0% Konfidenz

Risiko & Handel

Risikostufe3/5
Mittleres Risiko
Geeignet für
Wert
Handelsleitfaden

Einstiegspunkt

$77.85

Gewinnmitnahme

$79.56

Stop-Loss

$74.46

Schlüsselfaktoren

DMI zeigt bärischen Trend (ADX:13.0, +DI:5.1, -DI:7.4), was zur Vorsicht mahnt
Aktueller Preis ist extrem nah am Unterstützungsniveau ($78.11), was auf eine starke Kaufgelegenheit hindeutet
Handelsvolumen ist 9.0x Durchschnitt (4,249), was auf extrem starken Kaufdruck hindeutet
MACD -0.0749 liegt unter der Signallinie -0.0595, was auf einen bärischen Crossover hindeutet

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.